Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Improving Outcomes After Heart Failure Hospitalization
Clinical Breakthroughs

Improving Outcomes After Heart Failure Hospitalization

By Nora DunneFeb 26, 2015
Share
Facebook Twitter Email
Mihai Gheorghiade, MD, professor in Medicine-Cardiology and Surgery-Organ Transplantation, wrote a review examining the period following hospital discharge when patients with heart failure are vulnerable to adverse events.

About 30 percent of patients hospitalized with heart failure (HF) are readmitted within 90 days of discharge. During that same period, up to 15 percent of patients may die. In a recent paper published in Nature Reviews Cardiology, Northwestern Medicine investigators outline potential strategies to reduce the rate of early postdischarge adverse events among these patients.

Senior author Mihai Gheorghiade, MD, professor in Medicine-Cardiology and Surgery-Organ Transplantation, first author Stephen Greene, ’12 MD, resident in internal medicine at Northwestern Memorial Hospital, and colleagues have termed the immediate period following discharge from the hospital the “vulnerable phase.” Though patients are stable and often have minimal or absent signs and symptoms of heart failure when they leave the hospital, many die or are rehospitalized during this period, which may last two to three months.

“The single most important predictor of poor prognosis in chronic heart failure is hospitalization,” Gheorghiade said. “There’s no other medical condition for which patients are hospitalized, respond extremely well to therapies and then soon after discharge have this unacceptably high event rate that has not changed in the last 10 years.”

Stephen Greene, ’12 MD, resident in internal medicine, is a coauthor of the review.

A primary reason for this is that patients appear fine on the exterior, but leave the hospital with persistent cardiac congestion. Even though they feel much better, their heart pressures are still very abnormal. Minor triggers can worsen these pressures and cause severe symptoms to return.

“The hallmark of heart failure is an elevated left ventricular filling pressure,” Gheorghiade said. “Patients are being sent home with significant abnormalities there.”

The authors suggest several strategies for reducing early postdischarge events, including maximizing medical therapy for HF, aggressive treatment of heart pressures beyond signs and symptoms, considering digoxin therapy and optimizing comorbid illnesses.

“In an era of limited resources and financial pressures, recognition and understanding of the vulnerable phase after hospitalization for HF is crucial,” they write in the review. “Redirecting quality improvement and research initiatives towards patients in the postdischarge vulnerable phase is likely to be the most efficient, efficacious, and cost-effective strategy for addressing the public health and economic burden of HF.”

Cardiology Research
Share. Facebook Twitter Email

Related Posts

How ChatGPT Has, and Will Continue to, Transform Scientific Research

Mar 21, 2023

New Directions for HIV Treatment

Mar 21, 2023

Humans are Not Just Big Mice: Identifying Science’s Muscle-Scaling Problem

Mar 20, 2023

Comments are closed.

Latest News

How ChatGPT Has, and Will Continue to, Transform Scientific Research

Mar 21, 2023

New Directions for HIV Treatment

Mar 21, 2023

Humans are Not Just Big Mice: Identifying Science’s Muscle-Scaling Problem

Mar 20, 2023

AOA Honors New Members

Mar 20, 2023

Celebrating Feinberg’s 2023 Match Day

Mar 17, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230315_NM036
20230315_NM046
20230315_NM134
20230315_NM205
20230315_NM206
20230315_NM132
20230315_NM130
20230315_NM082
20230315_NM063
20230315_NM058
20230315_NM030
20230315_NM038

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.